Recombinant Vacuolar protein sorting-associated protein 33A (vps-33.1), partial

Shipped with Ice Packs
In Stock

Description

Definition and Functional Context

Recombinant Vacuolar Protein Sorting-Associated Protein 33A (VPS-33.1), partial, refers to a genetically engineered fragment of the VPS33A protein, a member of the Sec1/Munc18 (SM) family. This protein plays a critical role in intracellular membrane trafficking, particularly in endolysosomal pathways. In humans, VPS33A homologs interact with the HOPS (Homotypic Fusion and Vacuole Protein Sorting) complex to mediate vesicle tethering, SNARE complex assembly, and cargo delivery to lysosomes/vacuoles .

Domain Architecture

  • VPS-33.1 contains a conserved Sec1/Munc18-like domain critical for SNARE binding .

  • Partial constructs typically exclude transmembrane regions, focusing on soluble domains involved in protein-protein interactions .

Key Interactions

Interaction PartnerRoleExperimental Evidence
VPS11HOPS complex subunitCo-immunoprecipitation and genetic studies in yeast and C. elegans
Vam3 (Qa-SNARE)SNARE complex assemblyIn vitro binding assays with yeast Vps33
VPS16BStabilizes bidirectional complexStructural studies of human VPS33B-VPS16B homologs

Caenorhabditis elegans Studies

  • RNAi Knockdown: Loss of vps-33.1 disrupts endolysosomal trafficking, causing accumulation of aberrant vesicles and impaired yolk protein (vitellogenin) sorting .

  • Subcellular Localization: VPS-33.1::GFP localizes to lysosome-related gut granules and vacuolar membranes, unlike its paralog VPS-33.2, which associates with early endosomes .

Saccharomyces cerevisiae Mutational Analysis

  • Class C Phenotype: Full deletion of VPS33 results in fragmented vacuoles and missorting of carboxypeptidase Y (CPY) and alkaline phosphatase (ALP) .

  • Point Mutants:

    • D88K/I278N/D300G: Cytosolic mislocalization of VPS-33.1 and partial cargo maturation defects .

    • R281A/E653A: Complete loss of HOPS complex association, mimicking null phenotypes .

Experimental Applications

  • SNARE Binding Assays: Partial VPS-33.1 constructs retain affinity for Qa- (Vam3), Qc- (Vam7), and R-SNAREs (Nyv1), enabling studies of HOPS-SNARE interactions .

  • Disease Modeling: Mutations analogous to human VPS33A variants (e.g., F305L) show no yeast phenotype, highlighting species-specific functional divergence .

Clinical Relevance

  • Hermansky-Pudlak Syndrome (HPS): Human VPS33A mutations (e.g., I256L) impair melanosome and lysosome biogenesis .

  • ARC Syndrome: VPS33B mutations (e.g., L30P) disrupt apical protein trafficking in epithelial cells, but VPS-33.1 defects are linked to broader lysosomal deficiencies .

Product Specs

Form
Lyophilized powder. We will ship the in-stock format, but if you have special format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery times vary by purchase method and location. Consult your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs. For dry ice shipping, contact us in advance; additional fees apply.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon arrival. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you have a specific tag type requirement, please inform us, and we will prioritize its development.
Synonyms
vps-33.1; slp-1; B0303.9; Vacuolar protein sorting-associated protein 33A; Protein slp-1
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Caenorhabditis elegans
Target Names
vps-33.1
Uniprot No.

Target Background

Function
VPS-33A plays a role in vesicle-mediated protein trafficking to lysosomes, including endocytic pathways. It's a component of the HOPS complex, involved in rab-5-to-rab-7 endosome conversion, likely involving SAND-1. By binding SNAREs and SNARE complexes, it mediates tethering and docking during membrane fusion. HOPS, recruited to rab-7 on the late endosome, regulates late endocytic, phagocytic, and autophagic traffic to lysosomes. Within HOPS, VPS-33A contributes to gut granule development in embryonic and adult intestinal cells. It is essential for endosome/lysosome fusion and early embryonic development.
Database Links
Protein Families
STXBP/unc-18/SEC1 family
Subcellular Location
Lysosome. Early endosome. Late endosome. Apical cell membrane; Peripheral membrane protein.
Tissue Specificity
Ubiquitously expressed at high levels in somatic tissues including the pharynx, muscles, hypodermis, neurons, coelomocytes and spermatheca. Expressed in the intestine.

Q&A

What is the fundamental role of VPS-33.1 in the endolysosomal system?

VPS-33.1 serves as a critical regulator of membrane trafficking in the endolysosomal system. As a Sec1/Munc-18 (SM) family protein, VPS-33.1 functions as a core subunit of two tethering complexes: CORVET and HOPS. These complexes are essential for mediating the tethering, docking, and fusion events that characterize endolysosomal trafficking . In vivo and in vitro studies indicate that HOPS promotes tethering, docking, and fusion at the terminal lysosomal vacuole and further suggest that HOPS may proofread trans-SNARE complexes and shield trans-complexes from disassembly .

In C. elegans, VPS-33.1 is required for proper endocytic function and endolysosomal biogenesis. Null mutations in vps-33.1 result in severe defects in endocytosis across multiple tissues, and the complete loss of maternal and zygotic VPS-33.1 leads to embryonic lethality . This indicates that VPS-33.1 is essential for normal cellular development and function, particularly in the endolysosomal system.

The molecular mechanism of VPS-33.1 action involves direct binding to SNARE proteins, which are the core machinery for membrane fusion. VPS-33.1 binds to SNARE domains of proteins such as Vam3 (Qa-SNARE), Vam7 (Qc-SNARE), and Nyv1 (R-SNARE), showing highest affinity for fully assembled quaternary SNARE complexes . This binding pattern suggests that VPS-33.1 helps coordinate the assembly and/or stabilization of SNARE complexes during membrane fusion events in the endolysosomal pathway.

How do VPS-33.1 and VPS-33.2 differ functionally in organisms with both proteins?

Metazoan organisms possess two Vps33 proteins, VPS-33.1 (VPS33A) and VPS-33.2 (VPS33B), which have evolved distinct functional roles. Studies in C. elegans have provided significant insights into their differential functions through comparative analysis of null mutants .

VPS-33.1 (VPS33A) shares most of the general functions of yeast Vps33 in terms of tethering complexes in the endolysosomal system . It is broadly expressed and essential for endocytic function and endolysosomal biogenesis across multiple tissues. Mutations in vps-33.1 cause severe defects in endocytosis in scavenger cells and other tissues, and complete loss of both maternal and zygotic VPS-33.1 results in embryonic lethality .

In contrast, VPS-33.2 (VPS33B) appears to have more specialized, tissue-specific functions. In C. elegans, vps-33.2 mutants are viable but sterile, exhibiting terminally arrested spermatocytes . This suggests that VPS-33.2 is involved in the formation of a sperm-specific organelle rather than general endolysosomal functions. Importantly, the endocytosis defect in vps-33.1 mutants cannot be restored by expression of VPS-33.2, demonstrating that these proteins have non-redundant functions .

These functional differences are reflected in human pathology as well. Mutations in VPS33B are associated with ARC syndrome (Arthrogryposis, Renal dysfunction, and Cholestasis) . Many pathogenic mutations in VPS33B affect its interaction with VIPAS39/SPE-39, which appears to be a specific binding partner of VPS-33.2 but not VPS-33.1 . This further highlights the specialized roles of each protein in different cellular contexts.

What is the molecular basis for VPS-33.1 interactions with SNARE proteins?

The molecular interactions between VPS-33.1 and SNARE proteins occur through highly specific binding mechanisms that facilitate membrane fusion. Research has revealed several key aspects of these interactions:

VPS-33.1 directly binds to the SNARE domains of multiple SNAREs involved in vacuolar/endolysosomal fusion. Specifically, purified Vps33 has been shown to bind the SNARE domains of Vam3 (Qa-SNARE), Vam7 (Qc-SNARE), and Nyv1 (R-SNARE), but not Vti1 (Qb-SNARE) . This binding is selective, as Vps33 does not interact significantly with non-cognate SNAREs such as Sso1, Sed5, and Sec22 under optimized binding conditions .

A particularly notable feature of VPS-33.1 is its higher affinity for assembled quaternary SNARE complexes compared to individual SNAREs. The estimated dissociation constant for Vps33 and minimal SNARE complex is approximately 2.8 ± 0.2 μM, indicating a relatively strong interaction . When comparing binding efficiency, Vps33 is retained on SNARE complexes more efficiently than on any individual SNARE .

This preferential binding to assembled SNARE complexes suggests that VPS-33.1 may function to proofread or stabilize these complexes once they've formed, potentially preventing their disassembly before fusion has occurred. Importantly, Vps33 shows selectivity for vacuolar SNARE complexes over Golgi SNARE complexes, demonstrating pathway specificity .

Within the HOPS complex, VPS-33.1 is not the only subunit that interacts with SNAREs. Other HOPS subunits, particularly Vps11 and Vps18, are necessary for binding the N-terminal Habc domain of Vam3 (Qa-SNARE), while Vps33 specifically binds to the SNARE domains . This division of labor within the HOPS complex allows for coordinated regulation of SNARE assembly and function during membrane fusion events.

What structural features of VPS-33.1 enable its differential binding to SNARE complexes versus individual SNAREs?

The structural basis for VPS-33.1's preferential binding to assembled SNARE complexes over individual SNAREs involves specific domains and binding interfaces that have been partially characterized through biochemical and structural studies. SM proteins, including VPS-33.1, typically have an arch-shaped structure with three domains that create binding surfaces for SNARE interactions.

For binding to individual SNAREs, purified Vps33 shows selective interaction with the SNARE domains of specific vacuolar SNAREs. Binding experiments have demonstrated that Vps33 binds directly to the SNARE domains of Vam3 (Qa-SNARE), Vam7 (Qc-SNARE), and Nyv1 (R-SNARE), but not significantly to Vti1 (Qb-SNARE) or non-cognate SNAREs from other trafficking pathways . This selective binding to certain SNARE domains suggests the presence of specific recognition interfaces within the Vps33 structure.

The most striking feature of VPS-33.1 binding behavior is its significantly higher affinity for quaternary SNARE complexes compared to individual SNAREs. When comparing relative binding efficiencies, Vps33 binds more strongly to assembled SNARE complexes than to any individual SNARE . Quantitative binding measurements estimate the dissociation constant for Vps33 and the minimal SNARE complex at approximately 2.8 ± 0.2 μM, indicating a relatively strong interaction .

Insights from studies on the related protein Vps33b (VPS-33.2) suggest that a region equivalent to residues 221-260 in Vps33b corresponds to two small alpha-helical domains connected by a flexible loop . This region is buried deep in the structure in a connecting region between two Vps33b lobes equivalent to domains 1-2 and 3a-3b . Mutations in this region affect binding to specific interaction partners, suggesting its importance in mediating protein-protein interactions.

The structural features that enable VPS-33.1 to bind assembled SNARE complexes with higher affinity than individual SNAREs likely involve binding surfaces that recognize the unique quaternary structure formed when all four SNARE domains assemble into a coiled-coil bundle. This preferential recognition of assembled complexes is consistent with VPS-33.1's proposed role in proofreading and stabilizing correctly formed SNARE complexes during membrane fusion.

How are the interactions between VPS-33.1 and SNARE proteins regulated?

The regulation of interactions between VPS-33.1 and SNARE proteins involves multiple mechanisms that fine-tune binding affinities and specificities in response to cellular needs. Understanding these regulatory mechanisms provides insight into how membrane fusion events are controlled in the endolysosomal system.

One key regulatory mechanism involves the context in which VPS-33.1 functions. While VPS-33.1 can bind SNAREs directly as an isolated protein, it typically operates as part of the larger HOPS complex. Within this complex, VPS-33.1 works cooperatively with other subunits to coordinate SNARE interactions. For example, binding experiments have shown that the HOPS complex has at least two distinct Vam3-binding sites: Vps11 and Vps18 are necessary for binding the Vam3 Habc domain, while Vps33 binds the Vam3 SNARE domain . This division of labor within the complex allows for more sophisticated regulation of SNARE assembly and function.

The binding conditions significantly influence VPS-33.1-SNARE interactions. Experimental evidence shows that binding efficiency is affected by temperature, with binding at 30°C being more efficient than at 4°C . This temperature dependence suggests that conformational dynamics play a role in regulating these interactions, with higher temperatures potentially facilitating conformational changes that expose or optimize binding interfaces.

Binding specificity is another important regulatory aspect. While VPS-33.1 can interact with multiple vacuolar SNAREs (Vam3, Vam7, Nyv1), it shows selectivity for these over non-cognate SNAREs . Furthermore, VPS-33.1 binds with significantly higher affinity to quaternary SNARE complexes than to individual SNAREs . This preferential binding to assembled complexes suggests that VPS-33.1 recognizes structural features that only emerge when all four SNARE domains come together, allowing it to function as a proofreading mechanism that stabilizes correctly formed complexes.

What methodological approaches are most effective for studying VPS-33.1 binding to SNARE proteins?

Studying VPS-33.1 binding to SNARE proteins requires carefully designed methodological approaches that can accurately capture and characterize these molecular interactions. Based on published research, several effective strategies have been developed:

For protein preparation, recombinant expression systems have proven valuable. Vps33 has been successfully expressed and purified from insect cells, yielding functional protein that recapitulates the binding properties observed with native protein . For SNARE proteins, GST fusion constructs of either full cytoplasmic domains or isolated SNARE domains provide useful tools for binding studies . Importantly, the choice of expression system and purification strategy significantly impacts protein functionality.

In binding assays, pull-down experiments using immobilized GST-SNARE fusion proteins have been effectively employed to study Vps33-SNARE interactions. These assays can detect both direct binding to individual SNAREs and binding to pre-assembled SNARE complexes . The binding conditions are critical: optimal conditions for purified Vps33 include incubation at 30°C for 2 hours, which yields more efficient binding than incubation at 4°C . This temperature dependence highlights the importance of optimizing experimental conditions.

For detection and quantification, both Coomassie Blue staining and western blotting have been used effectively. With higher concentrations of Vps33 (5.0 μM), direct detection with Coomassie Blue staining is possible . For more sensitive detection of lower protein amounts, western blotting with specific antibodies provides greater sensitivity. Quantitative binding measurements can be performed by assaying binding over a range of protein concentrations to estimate dissociation constants .

Proper controls are essential for interpreting binding results. These include using GST alone to control for non-specific binding to the GST tag or matrix, testing binding to non-cognate SNAREs from different trafficking pathways (e.g., Golgi SNAREs) as specificity controls, and comparing binding to individual SNAREs versus assembled SNARE complexes . These controls allow researchers to distinguish specific, biologically relevant interactions from background binding.

For studying more complex interactions involving VPS-33.1 as part of larger protein assemblies, co-immunoprecipitation approaches have been effective. For example, researchers have co-expressed Vps33b-HA with Vps18-Myc or Vps41-Myc in HEK cells to examine how mutations affect Vps33b incorporation into complexes . Similar approaches can be applied to study VPS-33.1 interactions within the HOPS or CORVET complexes.

How do mutations in VPS-33.1 affect its function in different model systems?

Mutations in VPS-33.1 can have profound effects on its function, leading to diverse phenotypes across different model systems. The impact of these mutations ranges from mild trafficking defects to embryonic lethality, depending on the nature and location of the mutation.

In Caenorhabditis elegans, null mutations in vps-33.1 cause severe defects in endocytic function and endolysosomal biogenesis. These mutants exhibit impaired endocytosis in scavenger cells and other tissues, demonstrating the essential role of VPS-33.1 in the general endocytic pathway . Complete loss of both maternal and zygotic VPS-33.1 results in embryonic lethality, underscoring its critical function in development . Importantly, these defects cannot be rescued by expression of VPS-33.2, highlighting the non-redundant functions of these two proteins .

The differential effects of mutations highlight the modular nature of VPS-33 protein functions. Some mutations may specifically disrupt interactions with certain partners while preserving others, leading to pathway-specific defects rather than complete loss of function. Understanding the molecular consequences of specific mutations is crucial for interpreting the resulting phenotypes and for developing potential therapeutic strategies for related human diseases.

What are the implications of VPS-33.1 research for understanding human disease?

Research on VPS-33.1 has significant implications for understanding human diseases associated with endolysosomal dysfunction. While the search results don't directly mention VPS33A-specific human diseases, studies on the related protein VPS33B provide valuable insights into how disruptions in this protein family can lead to pathological conditions.

Mutations in VPS33B, the human homolog of C. elegans VPS-33.2, cause ARC syndrome (Arthrogryposis, Renal dysfunction, and Cholestasis), a rare autosomal recessive multisystem disorder . This highlights the critical role of VPS33 proteins in normal human development and physiology. The severity of ARC syndrome, which often leads to early mortality, underscores the fundamental importance of proper endolysosomal trafficking in human health.

Molecular studies have revealed that many pathogenic VPS33B mutations affect its interaction with VIPAS39/SPE-39, a specific binding partner . Most missense ARC, buff, and carnation-like defects cluster in a Vps33b region that is evolutionarily conserved from nematodes to chordates . Importantly, this region is required for VIPAS39/SPE-39 binding, yet is not necessary for Vps33b binding to either the late endosomal SNARE syntaxin 7, the Vps class C core, or the HOPS complex . This suggests that the disease mechanisms specifically involve disruption of the VPS33B-VIPAS39 interaction rather than a general loss of VPS33B function.

The tissue-specific effects of VPS33B mutations in humans parallel the findings in C. elegans, where vps-33.2 mutations primarily affect spermatogenesis rather than causing broad endocytic defects . This suggests that VPS-33.2/VPS33B has evolved specialized functions in certain tissues or organelles, while VPS-33.1/VPS33A retains the general endolysosomal functions. This functional specialization may explain why mutations in VPS33B cause tissue-specific manifestations in ARC syndrome rather than global cellular dysfunction.

By extension, potential mutations in human VPS33A (homologous to C. elegans VPS-33.1) would likely cause more severe and widespread cellular defects, potentially leading to embryonic lethality as observed in C. elegans . This may explain why clear disease-causing mutations in human VPS33A have not been well-characterized to date – they may be incompatible with development.

What protein expression systems are optimal for producing recombinant VPS-33.1?

Selecting the appropriate expression system is crucial for producing functional recombinant VPS-33.1 for research purposes. Based on published methodologies, several expression approaches have proven successful, each with distinct advantages for different experimental applications.

Insect cell expression systems have been effectively used to produce functional Vps33. The search results specifically mention that Vps33 was expressed and purified from insect cells for binding studies . This system offers several advantages for expressing eukaryotic proteins like VPS-33.1: it provides appropriate post-translational modifications, contains chaperones that facilitate proper folding, and generally yields higher amounts of soluble protein compared to bacterial systems. Importantly, the Vps33 produced in insect cells recapitulated the binding properties observed with native protein in yeast lysates, confirming its functional integrity .

For binding partners or interacting proteins, various expression systems have been employed. GST fusion proteins of SNARE domains or cytoplasmic domains have been successfully expressed, likely in bacterial systems, and used for pull-down assays . These fusion proteins provide a convenient handle for immobilization and detection while maintaining the binding interfaces necessary for interaction with Vps33.

For cellular studies examining protein-protein interactions in a more native context, mammalian expression systems have been utilized. For example, researchers have co-expressed tagged versions of Vps33b (Vps33b-HA) with other proteins (Vps18-Myc or Vps41-Myc) in HEK cells to study complex formation through co-immunoprecipitation . This approach allows for examination of protein interactions in a cellular environment that more closely resembles the native context.

The choice of purification strategy is also critical. Affinity tags such as GST or His-tags facilitate purification while potentially allowing for oriented immobilization in binding assays. For GST-tagged SNARE proteins, immobilization on glutathione-sepharose beads provides a convenient platform for pull-down assays . The specific purification approach for Vps33 from insect cells isn't detailed in the search results, but likely involved affinity chromatography followed by additional purification steps to ensure high purity and homogeneity.

When designing an expression strategy for recombinant VPS-33.1, researchers should consider the specific requirements of their experiments, including protein yield, purity, post-translational modifications, and the need for binding partners or complex assembly. For structural studies or in vitro binding assays requiring large amounts of highly pure protein, insect cell expression appears to be the method of choice based on published successes.

What experimental designs can distinguish between the functions of VPS-33.1 and VPS-33.2?

Distinguishing between the functions of VPS-33.1 and VPS-33.2 requires carefully designed experiments that leverage their distinct properties and interaction partners. Several experimental approaches have proven effective in delineating their specific roles:

Genetic analysis in model organisms provides a powerful approach for functional differentiation. In C. elegans, researchers generated null mutants for both vps-33.1 and vps-33.2 and characterized their distinct phenotypes . The vps-33.1 mutants exhibited severe defects in endocytic function and endolysosomal biogenesis across multiple tissues, while vps-33.2 mutants were viable but sterile due to arrested spermatocytes . These distinct phenotypes clearly demonstrate the non-redundant functions of these proteins.

Cross-rescue experiments offer a direct test of functional equivalence. In C. elegans, the endocytosis defect in vps-33.1 mutants could not be restored by expression of VPS-33.2, confirming that these proteins have non-overlapping functions despite their structural similarity . Similar approaches could be applied in other systems to test the ability of one protein to compensate for loss of the other.

Biochemical interaction studies can identify distinct binding partners. For VPS-33.2, VIPAS39/SPE-39 has been identified as a specific binding partner through yeast two-hybrid analysis . In contrast, VPS-33.2 does not appear to interact with Vps11 or Vps18 directly, suggesting a different mode of incorporation into protein complexes compared to VPS-33.1 . Systematic analysis of protein-protein interactions using techniques like yeast two-hybrid, co-immunoprecipitation, or proximity labeling can reveal distinct interaction networks for each protein.

Structure-function analysis can pinpoint specific domains responsible for differential functions. For example, pathogenic mutations in VPS-33.2 cluster in a region required for VIPAS39/SPE-39 binding . Domain swapping experiments, where segments from one protein are exchanged with the corresponding segments from the other, can identify regions responsible for specific functions or interactions. This approach can be particularly informative when combined with functional assays that test the chimeric proteins' abilities to rescue specific defects.

Subcellular localization studies can reveal different spatial distributions. If VPS-33.1 and VPS-33.2 operate in distinct compartments or associate with different membrane domains, this would support their non-redundant functions. Techniques like immunofluorescence microscopy, subcellular fractionation, or proximity labeling can map the spatial distribution of each protein relative to organelle markers and potential interaction partners.

These experimental approaches, used in combination, can comprehensively distinguish between the functions of VPS-33.1 and VPS-33.2, providing insights into their specialized roles within the endolysosomal system and beyond.

How can binding interactions between VPS-33.1 and SNARE complexes be accurately measured?

Accurately measuring binding interactions between VPS-33.1 and SNARE complexes requires sophisticated methodological approaches that can detect and quantify these molecular associations. Several effective techniques have been developed and optimized for this purpose:

GST pull-down assays have been successfully employed to study Vps33 binding to SNARE proteins and complexes. In this approach, GST-tagged SNARE proteins or domains are immobilized on glutathione-sepharose beads and incubated with purified Vps33 . After washing to remove unbound protein, the amount of Vps33 retained on the beads is analyzed, typically by SDS-PAGE followed by Coomassie staining or western blotting . This technique allows for comparison of relative binding efficiencies under different conditions or to different SNARE constructs.

Optimization of binding conditions is critical for accurate measurements. The search results highlight that binding of purified Vps33 to SNAREs is more efficient at 30°C for 2 hours compared to 4°C for the same duration . This temperature dependence suggests that conformational dynamics play a role in these interactions. Researchers should systematically optimize temperature, buffer composition, incubation time, and protein concentrations to ensure robust and reproducible binding measurements.

For quantitative affinity measurements, titration experiments can be performed. By varying the concentration of Vps33 and measuring the amount bound to immobilized SNARE complexes, researchers can generate binding curves and estimate dissociation constants (Kd). Using this approach, the dissociation constant for Vps33 and a minimal SNARE complex was estimated to be approximately 2.8 ± 0.2 μM . This provides a quantitative measure of binding affinity that can be compared across different conditions or mutant proteins.

Proper controls are essential for interpreting binding results. These should include: (1) GST alone to control for non-specific binding to the tag or matrix, (2) non-cognate SNAREs from different trafficking pathways to control for binding specificity, and (3) comparison of individual SNAREs versus assembled complexes to detect preferential binding . These controls help distinguish specific, biologically relevant interactions from background binding.

For more sophisticated analysis of binding kinetics and thermodynamics, techniques like surface plasmon resonance (SPR), bio-layer interferometry (BLI), or isothermal titration calorimetry (ITC) could be employed. While not explicitly mentioned in the search results, these approaches would provide real-time binding kinetics (kon and koff rates) and thermodynamic parameters (ΔH, ΔS) that offer deeper insights into the binding mechanism.

The most appropriate technique depends on the specific research question. For simple comparison of binding partners or mutants, pull-down assays may be sufficient. For detailed mechanistic studies or structure-function analyses, more quantitative approaches like SPR or ITC would be warranted. In all cases, careful attention to protein quality, binding conditions, and appropriate controls is essential for reliable results.

What in vitro reconstitution approaches can test VPS-33.1 function in membrane fusion?

In vitro reconstitution approaches provide powerful tools for dissecting the specific functions of VPS-33.1 in membrane tethering and fusion events. While the search results don't detail complete reconstitution systems, they provide insights into component preparation that can inform more complex reconstitution approaches.

Protein component preparation is a critical first step. The search results demonstrate successful expression and purification of functional Vps33 from insect cells, which retains its ability to bind SNARE proteins and complexes . Similarly, recombinant SNARE proteins can be produced as full cytoplasmic domains or isolated SNARE domains, typically as GST fusions . For complete functional studies, additional components of the HOPS complex would need to be similarly prepared, either as individual subunits or as subcomplexes.

SNARE complex assembly can be reconstituted in vitro as demonstrated in the search results. Quaternary complexes containing the cytoplasmic domains of Vti1, Vam7, and Nyv1 were assembled on solid supports bearing Vam3-GST . This approach allows for the systematic assembly of defined SNARE complexes that can then be used in binding studies with Vps33 or larger tethering complexes.

For membrane reconstitution, SNAREs and other membrane proteins would need to be incorporated into artificial membranes such as liposomes. While not explicitly described in the search results, standard approaches involve reconstituting full-length SNAREs (including transmembrane domains) into liposomes of defined lipid composition. These proteoliposomes can then be used in various fusion assays.

Tethering and docking assays could utilize either microscopy-based approaches or bulk assays. For microscopy, fluorescently labeled liposomes containing appropriate SNAREs could be observed in the presence or absence of Vps33/HOPS to measure tethering efficiency. Bulk tethering assays typically measure the increase in light scattering or turbidity when liposomes aggregate due to tethering activity.

Fusion assays provide the most direct test of VPS-33.1 function in membrane fusion. Standard approaches include lipid mixing assays (using fluorescent lipid dequenching) and content mixing assays (using fluorescent cargo dequenching or FRET). These assays can measure both the extent and kinetics of fusion, allowing for quantitative comparison between different conditions or protein variants.

Single-molecule approaches offer the highest resolution view of VPS-33.1 function. Techniques like total internal reflection fluorescence (TIRF) microscopy can visualize individual tethering and fusion events between surface-tethered and free liposomes. This approach can reveal mechanistic details that might be obscured in bulk assays.

By combining these reconstitution approaches, researchers can systematically test hypotheses about VPS-33.1's roles in tethering, SNARE complex assembly/stabilization, and membrane fusion. The ability to control the presence and stoichiometry of each component allows for precise determination of VPS-33.1's specific contributions to these processes.

How can contradictory findings about VPS-33.1 be reconciled through experimental design?

Reconciling contradictory findings about VPS-33.1 requires systematic experimental approaches that address potential sources of discrepancy. Several methodological strategies can help resolve conflicting results and develop a more cohesive understanding of VPS-33.1 function.

Standardizing experimental conditions is crucial, as binding interactions can be highly sensitive to specific parameters. The search results highlight how temperature significantly affects Vps33 binding to SNAREs, with binding at 30°C being more efficient than at 4°C . When conflicting results arise, researchers should carefully compare the experimental conditions used in different studies, including temperature, buffer composition, protein concentrations, and incubation times. Systematic variation of these parameters can identify conditions under which apparently contradictory results can be reconciled.

Using multiple complementary techniques provides stronger evidence than relying on a single approach. For example, the search results mention both yeast lysate pull-downs and experiments with purified proteins to study Vps33-SNARE interactions . When different techniques yield consistent results, confidence in the findings increases. Conversely, when techniques give different results, this may reveal interesting aspects of the interaction that depend on specific experimental contexts or additional factors present in more complex systems.

Examining protein context is essential, as interactions may differ between isolated domains and full-length proteins, or between individual proteins and multiprotein complexes. The search results describe how the HOPS complex has at least two Vam3-binding sites: Vps33 binds the SNARE domain, while other HOPS subunits (Vps11 and Vps18) bind the Habc domain . This division of binding sites helps reconcile apparently contradictory findings about which HOPS components interact with different regions of Vam3.

Quantitative binding measurements can resolve apparent contradictions by revealing differences in binding affinities rather than absolute "binds/doesn't bind" distinctions. The search results show that Vps33 has higher affinity for quaternary SNARE complexes (Kd ≈ 2.8 μM) than for individual SNAREs . What might appear as contradictory results in qualitative assays could be explained by different detection thresholds for interactions of varying strengths.

Structural validation through mutagenesis can identify specific residues critical for interactions. By introducing point mutations that disrupt specific interfaces and testing their effects on binding and function, researchers can determine the molecular basis for protein-protein interactions. This approach has been applied to Vps33b, where specific mutations (e.g., L30P) were shown to disrupt binding to VIPAS39/SPE-39 .

Functional correlation between biochemical and biological phenotypes provides the ultimate test of relevance. For example, the search results show that Vps33b mutations that disrupt VIPAS39/SPE-39 binding are associated with ARC syndrome . This correlation between molecular interaction defects and disease phenotypes supports the biological significance of the interaction. Similar approaches can help determine which of several contradictory biochemical findings is most relevant to VPS-33.1's biological function.

What are the major technical obstacles in VPS-33.1 research and potential solutions?

Research on VPS-33.1 faces several significant technical challenges that have limited our understanding of its precise molecular functions. Identifying these obstacles and developing strategies to overcome them is essential for advancing the field.

Protein expression and purification present substantial challenges. VPS-33.1 is a relatively large protein that functions as part of even larger multiprotein complexes (HOPS/CORVET), making recombinant expression challenging. While the search results demonstrate successful expression and purification of Vps33 from insect cells , scaling up production for structural studies or complex functional assays remains difficult. Potential solutions include optimizing expression constructs to improve solubility, exploring different expression systems, and developing co-expression strategies for producing entire complexes or stable subcomplexes.

Reconstituting functional HOPS/CORVET complexes is technically demanding due to their size and complexity. These hexameric complexes contain multiple large subunits that must assemble correctly to function. While researchers have made progress with individual components like Vps33 , fully reconstituted complexes for functional studies remain challenging. Approaches to address this include stepwise assembly from purified components, co-expression of multiple subunits using multicistronic vectors, and development of stabilized complex variants for structural and functional studies.

Studying membrane dynamics in real-time presents methodological difficulties. The transient nature of tethering and fusion events makes them challenging to capture and analyze. Advanced imaging techniques such as single-molecule microscopy, super-resolution imaging, or high-speed confocal microscopy could help visualize these events with the necessary temporal and spatial resolution. Development of new fluorescent probes or biosensors specific for active VPS-33.1 or assembled HOPS/CORVET complexes would also facilitate these studies.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.